These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2606148)
1. Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on blood vessels. Kondo K; Seo R; Omawari N; Imawaka H; Wakitani K; Kira H; Okegawa T; Kawasaki A Eur J Pharmacol; 1989 Sep; 168(2):193-200. PubMed ID: 2606148 [TBL] [Abstract][Full Text] [Related]
2. Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis. Kondo K; Seo R; Naka M; Kitagawa T; Wakitani K; Sakata M; Kira H; Okegawa T; Kawasaki A Eur J Pharmacol; 1989 Apr; 163(2-3):253-61. PubMed ID: 2721574 [TBL] [Abstract][Full Text] [Related]
3. Actions of the novel thromboxane A2 antagonists, ONO-1270 and ONO-3708, on smooth muscle cells of the guinea-pig basilar artery. Fujioka M; Nagao T; Kuriyama H Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):468-74. PubMed ID: 3821937 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481 [TBL] [Abstract][Full Text] [Related]
5. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
6. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species. Narumiya S; Okuma M; Ushikubi F Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697 [TBL] [Abstract][Full Text] [Related]
7. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation. Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953 [TBL] [Abstract][Full Text] [Related]
9. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161 [TBL] [Abstract][Full Text] [Related]
10. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction. Torii T; Toki Y; Hieda N; Ito Y; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T Heart Vessels; 1988; 4(2):104-11. PubMed ID: 3253270 [TBL] [Abstract][Full Text] [Related]
12. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations. Karasawa A; Shirakura S; Higo K; Kubo K Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. Altin JG; Bygrave FL Biochem J; 1988 Feb; 249(3):677-85. PubMed ID: 3128268 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of vasoconstriction induced by 9,11-epithio-11,12-methano-thromboxane A2 in the rabbit coronary artery. Kanmura Y; Itoh T; Kuriyama H Circ Res; 1987 Mar; 60(3):402-9. PubMed ID: 3581448 [TBL] [Abstract][Full Text] [Related]
15. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense. Yu SM; Ko FN; Wu TS; Lee JY; Teng CM Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563 [TBL] [Abstract][Full Text] [Related]
16. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis. Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320 [TBL] [Abstract][Full Text] [Related]
17. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed. McMahon TJ; Hood JS; Nossaman BD; Ibrahim IN; Feng CJ; Kadowitz PJ J Appl Physiol (1985); 1991 Nov; 71(5):2012-8. PubMed ID: 1837015 [TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 receptor characterization in human astrocytoma cells and rabbit platelets by a new thromboxane antagonist, [3H]ONO NT-126. Takano S; Ishimoto H; Nakahata N; Nakanishi H Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):155-70. PubMed ID: 1534919 [TBL] [Abstract][Full Text] [Related]
19. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory actions of ONO-3708 on the stretch-induced contraction potentiated by hemolysate/oxyhemoglobin studied in dog cerebral artery. Tanaka Y; Nakayama K; Shigenobu K Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):303-11. PubMed ID: 9485524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]